Condensed Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows (used in) operating activities:
Net (loss)	$ (308,966)	$ (148,222)
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Depreciation and amortization	48,570	42,525
Stock-based compensation expense related to stock options	22,651	25,011
Provision for potential inventory obsolescence	2,569	83,152
Change in operating assets and liabilities:
Right of use asset, net	56,656	(6,909)
Accounts receivable	24,524	74,127
Inventories	11,750	154,520
Prepaid expenses and other assets	(55,968)	15,935
Accounts payable	(49,487)	(26,678)
Accrued compensation and other accrued liabilities	5,552	(20,762)
Net cash (used in) provided by operating activities	(242,149)	192,699
Cash flows (used in) investing activities:
Acquisition of property and equipment	(43,215)	(42,559)
Patent and Trademark costs	(11,933)	(17,359)
Net cash (used in) investing activities	(55,148)	(59,918)
Cash flows from financing activities:
(Repayments) Borrowing from line of credit	(364,258)	(77,834)
(Payments) from options exercised	0	(1,449)
Proceeds from issuance of common stock	500,000	0
(Paydown) Draw on Secured notes	(24,147)	134,007
Net cash provided by financing activities	111,595	54,724
Net (decrease) increase in cash	(185,702)	187,505
Cash, beginning of fiscal year	257,433	42,509
Cash, end of six months	71,731	230,014
Supplemental disclosures of cash flow information:
Cash paid during the year for interest	$ 29,393	$ 16,967